Prenatal antidepressant exposure is associated with risk for attention-deficit hyperactivity disorder but not autism spectrum disorder in a large health system
Has this study been replicated?
The atlas records 1 replication of this study. Recorded outcomes: 1 mixed. The earliest on record is from 2016.
Replications
- Absence of evidence for increase in risk for autism or attention-deficit hyperactivity disorder following antidepressant exposure during pregnancy: a replication study, Castro et al. (2016). Translational Psychiatry. Outcome recorded: mixed.
The first quote supports the failed replication of the original ADHD association. The second supports consistency with the original ASD null finding, although it is not an explicit claim of successful replication.
Outcome read from the discussion. View paper
Cite this record
Clements, C. C., Castro, V. M., Blumenthal, S. R., Rosenfield, H. R., Murphy, S. N., Fava, M., Erb, J. L., Churchill, S. E., Kaimal, A. J., Doyle, A. E., Robinson, E. B., Smoller, J. W., Kohane, I. S., & Perlis, R. H. (2014). Prenatal antidepressant exposure is associated with risk for attention-deficit hyperactivity disorder but not autism spectrum disorder in a large health system. Molecular Psychiatry, 20(6), 727–734. https://doi.org/10.1038/mp.2014.90
Other studies in the atlas
Failed replications · Successful replications · All browse pages